Stay updated on Elranatamab vs Lenalidomide Post-Transplant Clinical Trial

Sign up to get notified when there's something new on the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A new revision label v3.5.4 has been added, signaling a minor platform update. The previous revision label v3.5.3 has been removed, without affecting study content or page functionality.
    Difference
    0.0%
    Check dated 2026-05-16T09:25:29.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    Added related topics entries for Multiple myeloma and MedlinePlus Genetics under the related topics section to provide background resources.
    Difference
    0.1%
    Check dated 2026-05-09T11:23:15.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The Taiwan site entry was updated from Taoyuan District, Taiwan, 333 to Taoyuan, Taiwan, 333.
    Difference
    0.0%
    Check dated 2026-05-02T05:08:58.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page’s interface version or release revision indicator was updated from v3.5.2 to v3.5.3. This represents a system display/update rather than a change to the clinical trial details.
    Difference
    0.0%
    Check dated 2026-04-24T22:41:23.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    MRD and PFS endpoints have been updated to IMWG 2025 terminology and subgroups, with added notes on next‑generation sequencing and longer follow-up. The study location count changed from 217 to 209 locations.
    Difference
    1%
    Check dated 2026-04-17T14:13:47.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Removed the disease keyword 'Multiple Myeloma' and the related topic 'MedlinePlus Genetics' from the page's topics section.
    Difference
    0.0%
    Check dated 2026-04-03T07:24:46.000Z thumbnail image

Stay in the know with updates to Elranatamab vs Lenalidomide Post-Transplant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page.